Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

45drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: S-1 ×

S-1

This drug is selected. Its supporting articles are shown below.

S-13

Articles mentioning S-1

3 articles · page 1 of 1

Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinoma

bmjonc · full text · 2025-07-21 · 39 matching annotations

98.5%

capecitabine S-1

…mens alone (PF vs GP) and (I–L) depict the oral regimens alone (capecitabine vs S-1); within each panel set the endpoints are, respectively,…

Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinoma

bmjonc · abstract · 2025-07-21 · 4 matching annotations

95.5%

capecitabine S-1 cisplatin tegafur gimeracil gemcitabine fluorouracil oteracil potassium capsule nasopharyngeal carcinoma CCRT

…induction chemotherapy and CCRT, oral chemotherapy, either with capecitabine or S-1, was efficacious and tolerable.…

Efficacy and safety of HIPEC combined with PD-1 and SOX chemotherapy for gastric or oesophagogastric junctional cancer with peritoneal metastasis (HISTORIA): protocol for a prospective, multicentre, single-arm, phase II study

bmjopen · abstract · 2025-09-14 · 2 matching annotations

86.5%

trastuzumab tislelizumab oxaliplatin paclitaxel S-1 SOX oesophagogastric junction cancer gastric cancer The First Affiliated Hospital of Nanjing Medical University ClinicalTrials.gov+2 more

…by body surface area). HER2-positive patients will also receive trastuzumab. Primary endpoint: 1-year overall survival. Secondary endpoints…